Medical Marijuana Inc (MJNA)

[scoobey-do]

MJNA owns 18% of AXIM. The following is from MJNA's current 10-Q:

2. AXIM® Biotechnologies, Inc. AXIM® Biotechnologies, Inc. (“AXIM®”) (OTCBB: AXIM).
AXIM® Founded in 2014, AXIM® is a vertically integrated oncology company developing diagnostic tests
for the early detection of cancer, proprietary small molecules drugs not only to treat cancer but also to block
metastasis and developing novel antibodies for therapeutic and diagnostic uses. AXIM is also developing new
cannabinoid molecules for oncological therapeutics. Currently, the Sapphire Biotech, Inc. diagnostic tool is
being used to study the company's enzyme biomarker to detect pancreatic cancer earlier than circulating tumor
cells. The Company currently owns approximately 18% of AXIM’s® issued and outstanding common stock.

https://backend.otcmarkets.com/otcapi/company/financial-report/255495/content